Susan Wyrick

2013

In 2013, Susan Wyrick earned a total compensation of $431.9K as Principal Accounting Officer and Vice President, Finance at OncoGenex Pharmaceuticals, a 60% increase compared to previous year.

Compensation breakdown

Bonus$5,000
Non-Equity Incentive Plan$40,000
Option Awards$77,656
Salary$200,000
Stock Awards$109,248
Total$431,904

Wyrick received $200K in salary, accounting for 46% of the total pay in 2013.

Wyrick also received $5K in bonus, $40K in non-equity incentive plan, $77.7K in option awards and $109.2K in stock awards.

Rankings

In 2013, Susan Wyrick's compensation ranked 9,821st out of 12,286 executives tracked by ExecPay. In other words, Wyrick earned more than 20.1% of executives.

ClassificationRankingPercentile
All
9,821
out of 12,286
20th
Division
Manufacturing
3,651
out of 4,612
21st
Major group
Chemicals And Allied Products
1,158
out of 1,462
21st
Industry group
Drugs
903
out of 1,156
22nd
Industry
In Vitro and In Vivo Diagnostic Substances
39
out of 56
30th
Source: SEC filing on April 24, 2014.

Wyrick's colleagues

We found three more compensation records of executives who worked with Susan Wyrick at OncoGenex Pharmaceuticals in 2013.

2013

Scott Cormack

OncoGenex Pharmaceuticals

Chief Executive Officer

2013

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

2013

Michelle Burris

OncoGenex Pharmaceuticals

Chief Financial Officer

You may also like